Research lines
Our current research activity is divided in the following lines:
In silico testing
​Computational electromagnetism and in silico clinical trials
Starting from animal and human computable phantoms, we perform computer simulations of therapies and diagnostic techniques based on the interaction of electromagnetic fields and nanomaterials in the frequency range of kHz.​
​
The group collaborates closely with some hospitals and medical devices manufacturers based in Europe, and is currently involved in a European project on treating pancreatic cancer through magnetic hyperthermia that aims to enter phase I clinical trials. Our mission is to provide clinicians with a powerful tool to choose the best therapeutical conditions, and to predict the body response, which will eventually lead to personalized cancer treatments.
​
Design of multifunctional nanomaterials
Biocompatible magnetic nanomaterials for therapy and diagnostics
We design and synthesise a wide range of magnetic nanomaterials applied to biomedicine; for example, magnetic hyperthermia (MH), brain imaging contrasts, and magnetic particle imaging (MPI) tracers. Within this research line, the combination of magnetic hyperthermia and MPI is our current priority.
​
Point-of-care testing for cancer relapse
We collaborate with researchers at the University of Electrocommunications in Tokyo and Vall d'Hebron Institue of Oncology in Barcelona to design a nanotechnology-enabled point-of-care tests to monitor cancer patients after treatment. Our main goal is the early detection of cancer relapse.